GBA1 and Parkinson disease: In diagnosis and treatment of PD, it is beneficial to distinguish those patients with mutations in the glucocerebrosidase (GBA) gene from those with sporadic PD lacking such mutations; such mutations are found in 5–20% of PD cases and their symptoms and treatment options differ somewhat [9].